Characteristics of extracellular nuclease production in Staphylococcus aureus.
D003523:Cycloserine / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D004917:Erythromycin / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D046911:Macromolecular Substances; D008320:Maltose / Q000494:pharmacology; D008836:Micrococcal Nuclease / Q000096:biosynthesis*; D009268:Nalidixic Acid / Q000494:pharmacology; D013211:Staphylococcus aureus / Q000201:enzymology* / Q000254:growth & development
D046911:Macromolecular Substances; D003609:Dactinomycin; D009268:Nalidixic Acid; D004917:Erythromycin; D008320:Maltose; D003523:Cycloserine; D008836:Micrococcal Nuclease; D005947:Glucose